SEC Comment Letter 0000000000-24-009628 to REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH, RVPHW) (CIK 0001742927) (RVPH)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH, RVPHW) (CIK 0001742927)
Date: Aug. 22, 2024 · CIK: 0001742927 · Accession: 0000000000-24-009628
AI Filing Summary & Sentiment
File numbers found in text: 001-38634
Letter
August 22, 2024 Narayan Prabhu Chief Financial Officer Reviva Pharmaceuticals Holdings, Inc. 10080 N. Wolfe Road, Suite SW3-200 Cupertino, CA 95014 Re:Reviva Pharmaceuticals Holdings, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-38634 Dear Narayan Prabhu: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
August 22, 2024
Narayan Prabhu
Chief Financial Officer
Reviva Pharmaceuticals Holdings, Inc.
10080 N. Wolfe Road, Suite SW3-200
Cupertino, CA 95014
Re:Reviva Pharmaceuticals Holdings, Inc.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 001-38634
Dear Narayan Prabhu:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences